SENP8 Knockout HEK293 Cell Line
Cat.No.:
EDC07587
Species:
Human
Cell Name:
HEK293
Gene:
SENP8
Gene ID:
123228
Size:
1×10⁶cells
SENP8 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07587 |
|---|---|
| Product Name | SENP8 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SENP8 |
| NCBI Gene ID | |
| Gene Synonyms | DEN1|NEDP1|PRSC2 |
| Summary |
This gene encodes a cysteine protease that is a member of the sentrin-specific protease family. The encoded protein is involved in processing and deconjugation of the ubiquitin-like protein termed, neural precursor cell expressed developmentally downregulated 8. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SENP8 function, SENP8 Knockout HEK293 Cell Line or SENP8 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SENP8 (also known as DEN1/NEDP1)'s role as the principal NEDD8-specific protease or its functions in regulating cullin-RING E3 ligase activity. Important note: despite the 'SENP' (SUMO-Specific Protease) name, SENP8 is a NEDD8-specific protease, not a SUMO protease. It is essential for processing the NEDD8 precursor and for deconjugating NEDD8 from non-cullin substrates. The Knockout line is the standard tool for asking whether SENP8 is required for these processes — SENP8 loss disrupts NEDD8 homeostasis and impairs cullin neddylation regulation.
For NEDD8 biology research, the EDITGENE SENP8 Knockout in HEK293 is a mechanistic platform — HEK293 supports the biochemical and proteomic analyses needed for NEDD8 substrate characterization. Rescue with wild-type or catalytically-dead (C163S) SENP8 is the standard specificity control. The knockout is valuable for studying neddylation pathway regulation and for testing NEDD8 pathway inhibitors (MLN4924/pevonedistat) in mechanism research.
What are the application scenarios for this model?
Primary applications:
• NEDD8 maturation: NEDD8 precursor processing analysis by Western blot — SENP8 cleaves the C-terminal extension to generate mature NEDD8.
• Cullin neddylation: cullin family (CUL1-5, CUL7, CUL9) neddylation status analysis given SENP8's regulation of cullin-RING E3 ligases.
• Non-cullin NEDD8 substrates: deNEDDylation of non-cullin substrates analyzed by ubiquitin remnant proteomics.
• MLN4924 specificity: critical genetic control for testing NEDD8 pathway inhibitors (pevonedistat/MLN4924) in development for cancer therapy.
EDITGENE recommends this model for researchers investigating NEDD8 biology, cullin-RING E3 ligase regulation, and neddylation pathway therapeutics.
Is this SENP8 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. SENP8 rescue experiments are well-established for NEDD8 pathway research:
• Construct design: use a codon-modified SENP8 sequence with a small C- or N-terminal tag (FLAG, HA). SENP8 is small (~212 amino acids); both tag positions are typically tolerated.
• Catalytically-dead rescue: the C163S mutation in the active site cysteine abolishes deNEDDylase activity and is the standard specificity control.
• Functional readout: rescue should restore NEDD8 precursor processing (mature NEDD8 generation) and cullin neddylation status.
• MLN4924 mechanism studies: rescue with wild-type or catalytically-dead SENP8 enables on-target validation of NEDD8 E1 inhibitor pevonedistat effects.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download